← Leaderboards
Kevin D Judy
University Of Pennsylvania
$804,716
Attributed
$804,716
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$804,716 · 3
By mechanism
R01$796,592 · 1
M01$8,124 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Steven Mark Albelda$22,046,338
- Daniel Sterman$5,215,085
- Stephen G Emerson$28,932,839
- Donald M Coen$28,460,204
- William M Lee$5,600,205
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectGliomaPatient Oriented ResearchClinical ResearchClinical Trial Phase IHuman Therapy EvaluationDosageNeoplasm /Cancer ImmunotherapyTransfection /Expression VectorBioimaging /Biomedical ImagingBrain Imaging /Visualization /ScanningGene Delivery SystemGene TherapyInterferon BetaPositron Emission TomographyThymidine KinaseClinical Trial Phase IiHypoxiaImmunoconjugatesImmunotoxicityAntineoplasticsInterleukin 13Neoplasm /Cancer Blood SupplyNeoplasm /Cancer Chemotherapy
Grant awards (5)
UPCC 1301: ASSESSMENT OF HYPOXIA IN MALIGNANT GLIOMAS USING EF5$1,023
M01 · FY2005 · RR
Interstitial Infusion of IL 13-PE38QQR Cytotoxin in Recurrent Malignant Glioma$5,681
M01 · FY2004 · RR
UPCC 1301: Assessment of Hypoxia in Malignant Gliomas Using EF5$1,420
M01 · FY2004 · RR
GENE-BASED THERAPIES AND IMAGING OF MALIGNANT GLIOMAS$403,424
R01 · FY2003 · CA
GENE-BASED THERAPIES AND IMAGING OF MALIGNANT GLIOMAS$393,168
R01 · FY2002 · CA